P-204Prognostic value of neo-adjuvant treatment in localized rectal cancer about 78 cases

Introduction: The frequency of colorectal adenocarcinoma continues to increase, which is the leading cause of cancer deaths in developed countries. Unlike colon cancer, there is currently no compelling evidence for the value of adjuvant chemotherapy in rectal cancer. Preoperative chemoradiotherapy has become the standard for middle and low rectum tumors, improving local control without improving survival without metastatic relapse and overall survival.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research